Clinical
News
Post-COVID clinics get jump-start from patients with lingering illness
That need has jump-started post-COVID clinics, which bring together a range of specialists into a one-stop shop.
News
AHA scientific statement highlights cardiorenal benefit of new diabetes drugs
SGLT2 inhibitors and GLP-1 receptor agonists should be considered in people with type 2 diabetes and chronic kidney disease to protect against...
News
COVID-19 shutdown fuels sharp rise in alcohol use
After some states issued stay-at-home orders, one study noted a 54% increase in national sales of alcohol for the week ending March 21, compared...
News
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use
Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25....
News
COVID-19 airway management: Expert tips on infection control
“We will always observe standard precautions, which include hand hygiene, gloves, hair and eye cover, medical mask, and face shield,” Dr. Charles...
News
J&J’s one-shot COVID-19 vaccine advances to phase 3 testing
J&J’s vaccine is unusual in that it will be tested based on a single dose, while other advanced candidates have been tested in two-dose...
News
CDC playbook prepares states for rollout of COVID-19 vaccine if one is approved
The agency has asked states to submit plans for vaccine distribution by mid-October.
News
Three major COVID vaccine developers release detailed trial protocols
Typically, manufacturers guard the specifics of preclinical vaccine trials. This rare move follows calls for greater transparency.
News
Children’s share of COVID-19 burden continues to increase
Over the course of 1 week, almost 17% of all U.S. cases occurred in children.
News
Signs of an ‘October vaccine surprise’ alarm career scientists
If the executive branch were to overrule the FDA’s scientific judgment, a vaccine of limited efficacy and, worse, unknown side effects could be...